IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
31 hedge funds and large institutions have $6.26M invested in ImmunoCellular Therapeutics, Ltd. in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
31
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
| 1 | +$610K | |
| 2 | +$593K | |
| 3 | +$142K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$51K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$29K |
Top Sellers
| 1 | -$1.2M | |
| 2 | -$997K | |
| 3 | -$178K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$112K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$60K |